Top Drugstores & Retail Pharmacies companies in United States by Net Income
United States
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 14.68 B
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
| 2 |
USD 5.02 B
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
| 3 |
USD 2.77 B
|
Nov. 9, 2024 | USD 59.92 | 0.72% |
|
United States |
|
| 4 |
USD 2.54 B
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
| 5 |
USD 1.51 B
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
| 6 |
USD 1.20 B
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
| 7 |
USD 1.04 B
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
| 8 |
USD 924.00 M
|
Nov. 2, 2024 | USD 36.79 | 0.03% |
|
United States |
|
| 9 |
USD 753.70 M
|
Sept. 30, 2024 | USD 627.71 | 1.49% |
|
United States |
|
| 10 |
USD 395.62 M
|
Sept. 30, 2024 | USD 39.22 | 1.63% |
|
United States |
|
| 11 |
USD 196.76 M
|
Oct. 31, 2024 | USD 72.63 | 1.31% |
|
United States |
|
| 12 |
USD 195.47 M
|
Sept. 26, 2024 | USD 95.99 | -0.72% |
|
United States |
|
| 13 |
USD 105.54 M
|
Sept. 28, 2024 | USD 63.79 | -0.65% |
|
United States |
|
| 14 |
USD 95.79 M
|
Sept. 28, 2024 | USD 66.75 | 0.48% |
|
United States |
|
| 15 |
USD 86.60 M
|
Sept. 30, 2024 | USD 6.18 | -4.33% |
|
United States |
|
| 16 |
USD 64.59 M
|
Sept. 30, 2024 | USD 17.68 | 0.68% |
|
United States |
|
| 17 |
USD 33.94 M
|
Sept. 30, 2024 | USD 38.98 | 0.72% |
|
United States |
|
| 18 |
USD 30.34 M
|
Sept. 28, 2024 | USD 35.65 | -0.17% |
|
United States |
|
| 19 |
USD 10.04 M
|
Sept. 30, 2024 | USD 5.67 | 2.35% |
|
United States |
|
| 20 |
USD 3.82 M
|
Nov. 2, 2024 | USD 11.50 | 1.23% |
|
United States |
|
| 21 |
USD -963.00 K
|
Sept. 30, 2024 | USD 4.88 | 0.62% |
|
United States |
|
| 22 |
USD -1.46 M
|
Sept. 30, 2024 | USD 12.40 | -1.20% |
|
United States |
|
| 23 |
USD -6.25 M
|
Sept. 30, 2024 | USD 1.64 | -2.96% |
|
United States |
|
| 24 |
USD -7.09 M
|
Sept. 30, 2024 | USD 54.16 | 0.43% |
|
United States |
|
| 25 |
USD -7.81 M
|
Dec. 31, 2023 | USD 3.79 | 1.24% |
|
United States |
|
| 26 |
USD -7.92 M
|
Sept. 30, 2024 | USD 4.15 | -1.66% |
|
United States |
|
| 27 |
USD -12.84 M
|
Sept. 30, 2024 | USD 1.05 | -7.08% |
|
United States |
|
| 28 |
USD -17.69 M
|
Sept. 30, 2024 | USD 42.32 | NA |
|
United States |
|
| 29 |
USD -34.68 M
|
Sept. 30, 2024 | USD 14.98 | -0.13% |
|
United States |
|
| 30 |
USD -40.60 M
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
| 31 |
USD -444.00 M
|
Sept. 30, 2024 | USD 8.97 | -1.75% |
|
United States |
|
| 32 |
USD -883.30 M
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
| 33 |
USD -8.83 B
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
Frequently Asked Questions
-
Which Drugstores & Retail Pharmacies company in United States has the highest Net Income ?
The Drugstores & Retail Pharmacies company in United States with the highest Net Income is Johnson & Johnson (NYSE: JNJ) at USD 14.68 B.
-
Which Drugstores & Retail Pharmacies company in United States has the lowest Net Income ?
The Drugstores & Retail Pharmacies company in United States with the lowest Net Income is Walgreens Boots Alliance, Inc. (NasdaqGS: WBA) at USD -8.83 B.
-
What are the top 10 Drugstores & Retail Pharmacies companies in United States by Net Income ?
The top 10 Drugstores & Retail Pharmacies companies in United States by Net Income are Johnson & Johnson, CVS Health Corporation, The Kroger Co., McKesson Corporation, Cencora, Ulta Beauty, Inc., Albertsons Companies, Inc., Bath & Body Works, Inc., Lennox International Inc. and National Retail Properties, Inc..
-
What are the bottom 10 Drugstores & Retail Pharmacies companies in United States by Net Income ?
The bottom 10 Drugstores & Retail Pharmacies companies in United States by Net Income are Walgreens Boots Alliance, Inc., Viatris Inc., Icahn Enterprises L.P., BrightSpring Health Services, Inc. Common Stock, Xponential Fitness, Inc., Omnicell, Inc., Biofrontera Inc., GoodRx Holdings, Inc., Pilulka Lékárny a.s. and ANI Pharmaceuticals, Inc..